Neuroactive steroids and seizure susceptibility

被引:84
作者
Beyenburg, S
Stoffel-Wagner, B
Bauer, J
Watzka, M
Blümcke, I
Bidlingmaier, F
Elger, CE
机构
[1] Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany
[2] Univ Bonn, Dept Neuropathol, D-53105 Bonn, Germany
[3] Univ Bonn, Dept Clin Biochem, D-53105 Bonn, Germany
关键词
neuroactive steroids; neurosteroids; neuronal excitability; seizures; epilepsy;
D O I
10.1016/S0920-1211(01)00194-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is increasing clinical and experimental evidence that hormones, in particular sex steroid hormones, influence neuronal excitability and other brain functions. The term 'neuroactive steroids' has been coined for steroids that interact with neurotransmitter receptors. One of the best characterized actions of neuroactive steroids is the allosteric modulation of GABA(A)-receptor function via binding to a putative steroid-binding site. Since neuroactive steroids may interact with a variety of other membrane receptors, excitatory as well as inhibitory, they may have an impact on the excitability of specific brain regions. Neuronal excitability is enhanced by estrogen, whereas progesterone and its metabolites exert anticonvulsant effects. Testosterone and corticosteroids have less consistent effects on seizure susceptibility. Apart from these particular properties, neuroactive steroids may regulate gene expression via progesterone receptors. Based on their molecular properties, these compounds appear to have a promising therapeutical profile for the treatment of different neuropsychiatric diseases including epilepsy. This review focuses on the effects of neuroactive steroids on neuronal excitability and their putative impact on the physiology of epileptic disorders. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 153
页数:13
相关论文
共 117 条
[91]   Estrogen is more than just a "sex hormone": Novel sites for estrogen action in the hippocampus and cerebral cortex - Commentary [J].
Shughrue, PJ ;
Merchenthaler, I .
FRONTIERS IN NEUROENDOCRINOLOGY, 2000, 21 (01) :95-101
[92]   GABAA receptor function in epileptic human dentate granule cells:: comparison to epileptic and control rat [J].
Shumate, MD ;
Lin, DD ;
Gibbs, JW ;
Holloway, KL ;
Coulter, DA .
EPILEPSY RESEARCH, 1998, 32 (1-2) :114-128
[93]   LOCALLY APPLIED ESTROGENS POTENTIATE GLUTAMATE-EVOKED EXCITATION OF CEREBELLAR PURKINJE-CELLS [J].
SMITH, SS ;
WATERHOUSE, BD ;
WOODWARD, DJ .
BRAIN RESEARCH, 1988, 475 (02) :272-282
[95]   Characterization of aromatase cytochrome P450 activity in the human temporal lobe [J].
Steckelbroeck, S ;
Heidrich, DD ;
Stoffel-Wagner, B ;
Hans, VHJ ;
Schramm, J ;
Bidlingmaier, F ;
Klingmüller, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2795-2801
[96]  
Steckelbroeck S, 1999, J NEUROENDOCRINOL, V11, P457
[97]   EFFECT OF CERTAIN PROGESTINS AND ESTROGENS ON THRESHOLD OF ELECTRICALLY INDUCED SEIZURE PATTERNS [J].
STITT, SL ;
KINNARD, WJ .
NEUROLOGY, 1968, 18 (03) :213-&
[98]   Expression of 5α-reductase in the human temporal lobe of children and adults [J].
Stoffel-Wagner, B ;
Watzka, M ;
Steckelbroeck, S ;
Wickert, L ;
Schramm, J ;
Romalo, G ;
Klingmüller, D ;
Schweikert, HU .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3636-3642
[99]   Expression of 17β-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe [J].
Stoffel-Wagner, B ;
Watzka, M ;
Steckelbroeck, S ;
Schramm, J ;
Bidlingmaier, F ;
Klingmüller, D .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :119-126
[100]   Expression of CYP19 (aromatase) mRNA in the human temporal lobe [J].
Stoffel-Wagner, B ;
Watzka, M ;
Steckelbroeck, S ;
Schwaab, R ;
Schramm, J ;
Bidlingmaier, F ;
Klingmüller, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (03) :768-771